Treatment delayed tumor growth, increased proinflammatory cytokine expression in tumor tissue, increased i.t. CD8+ T cells, and reduced i.t. TGFβ which correlated with i.t. Treg reduction (102). The gene discussed is CD8A; the disease is neoplasm.